(Press-News.org) Washington, D.C. December 8, 2025 -- A new statewide spatial analysis of Alzheimer’s disease and related dementias (ADRD) has uncovered significant disparities in Maryland’s rural communities, offering a striking example of how healthcare accessibility is shaping health outcomes across the United States.
More than 90% of larger hospitals are located in urban areas, leaving rural hospitals with fewer resources and very small operating margins. One of the biggest challenges is the shortage of doctors, nurses, and specialists trained in Alzheimer's and dementia care, who are concentrated in urban centers. As a result, patients in rural areas, many of whom are over 80 years old, often face the additional burden of traveling much longer distances to access the care they need.
Alzheimer’s disease affects more than 6.9 million Americans, and its prevalence is expected to double by 2060, according to the Alzheimer’s Association. This research demonstrates that where a person lives can determine whether they receive timely diagnosis and care or whether they fall through the cracks.
The study analyzed 422,735 patients in Maryland in 2019, identifying reveal that many ADRD cases may remain in underserved rural areas, particularly in eastern and western Maryland, where high mortality rates coincide with low diagnosis rates. These results come amid ongoing funding challenges serious consequences for older and underserved populations.
By identifying hospital accessibility, demographic factors, and comorbidities like diabetes ADRD patterns, the study provides evidence that could inform targeted policy interventions in clinics, hospitals, and outreach programs not just in Maryland, but across rural America.
KEY FINDINGS:
Underserved regions in eastern and western Maryland show high ADRD mortality rates despite low diagnosis rates, suggesting that many cases remain undiagnosed.
Hospital accessibility is unevenly distributed, with urban areas having significantly better access than rural areas, where mortality rates are elevated.
Spatial regression analysis (Getis-Ord G* and GWR models) revealed that lower hospital accessibility is associated with higher poverty rates and higher health risk rates, including diabetes and heart disease.
Regional variations in these relationships were confirmed through spatial analysis, demonstrating that localized factors significantly influence ADRD outcomes.
EDITORS NOTE:
This research will be presented on December 8 at 6:00 P.M. EST at the Society for Risk Analysis (SRA) Annual Conference at the Downtown Westin Hotel in Washington, D.C. SRA Annual Conference welcomes press attendance. Please contact Emma Scott at emma@bigvoicecomm.com to register
About Society for Risk Analysis
The Society for Risk Analysis (SRA) is a multidisciplinary, global organization dedicated to advancing the science and practice of risk analysis. Founded in 1980, SRA brings together researchers, practitioners, and policymakers from diverse fields including engineering, public health, environmental science, economics, and decision theory. The Society fosters collaboration and communication on risk assessment, management, and communication to inform decision-making and protect public well-being. SRA supports a wide range of scholarly activities, publications, and conferences. Learn more at www.sra.org.
Media Contact:
Emma Scott
Media Relations Specialist
Emma@bigvoicecomm.com
(740) 632-0965
END
New study exposes hidden Alzheimer’s 'hot spots' in rural Maryland and what they reveal about America’s growing healthcare divide
New research shows that where a person lives can determine whether they receive timely diagnosis and care or whether they fall through the cracks
2025-12-08
ELSE PRESS RELEASES FROM THIS DATE:
ASH 2025: Study connects Agent Orange exposure to earlier and more severe cases of myelodysplastic syndrome
2025-12-08
MIAMI, FLORIDA (EMBARGOED UNTIL DEC. 8, 2025, AT 6 P.M. EST) – A new national study shows for the first time that people exposed to Agent Orange face a higher risk of developing myelodysplastic syndrome (MDS), tend to develop it earlier, and often have more aggressive disease that is more likely to progress to acute myeloid leukemia. The study was co-led by researchers at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine.
Many veterans and doctors have long questioned whether Agent Orange exposure ...
ASH 2025: New data highlights promise of pivekimab sunirine in two aggressive blood cancers
2025-12-08
Two clinical studies demonstrate high response rates by patients with two hard-to-treat and aggressive blood cancers
Pivekimab sunirine (PVEK) targets the CD123 antigen, which is overexpressed in both diseases
Frontline triplet regimen including PVEK shows promise for hard-to-treat AML in patients who are not eligible for intensive chemotherapy
PVEK monotherapy demonstrates strong responses, enables stem cell transplant for high-risk subgroup of BPDCN patients
ORLANDO, DECEMBER 8, 2025 – Researchers from The ...
IADR elects George Belibasakis as vice-president
2025-12-08
Alexandria, VA, USA – Members of the International Association for Dental, Oral, and Craniofacial Research (IADR) have elected George Belibasakis, Karolinska Institutet, Stockholm, Sweden to serve as Vice-president. His term will commence at the conclusion of the 104th General Session of the IADR, which will be held in conjunction with the 55th Annual Meeting of the AADOCR and the 50th Annual Meeting of the Canadian Association for Dental Research, from March 25-28, 2026 in San Diego, CA, USA.
Belibasakis is currently Professor of Clinical Oral Infection Biology, Head of the Division of Oral Health and Periodontology, and Head of Research at the Department of Dental Medicine, ...
Expanding the search for quantum-ready 2D materials
2025-12-08
Quantum technologies from ultrasensitive sensors to next-generation information processors depend on the ability of quantum bits, or qubits, to maintain their delicate quantum states for a sufficiently long time to be useful.
One of the most important measures of this stability is the spin coherence time. Unfortunately, qubits may lose coherence because their environment is “noisy,” for example, due to the presence of nuclear isotopes or other interference that disturbs the qubit.
Two-dimensional (2D) materials—or atomically thin sheets—can offer quiet environments for qubits, as their reduced thickness naturally lowers the number of isotopes that interact ...
White paper on leadership opportunities for AI to increase employee value released by University of Phoenix College of Doctoral Studies
2025-12-08
University of Phoenix College of Doctoral Studies announces a new white paper, “Leadership Opportunities for Increasing Employee Value through Artificial Intelligence,” authored by Andrew C. Lawlor, PhD, and Pamayla E. Darbyshire, DHA, MSN/CNS, both Fellows at the Center for Educational and Instructional Technology Research (CEITR). The paper examines how leaders can use AI, especially generative AI, to address skills gaps, restore worker autonomy, and shift employees from repetitive tasks to higher-value activities.
The authors draw upon the University’s Career Optimism Index® study and other current research, ...
ASH 2025: New combination approach aims to make CAR T more durable in lymphoma
2025-12-08
MIAMI, FLORIDA (EMBARGOED UNTIL DEC. 8, 2025, AT 4:30 P.M. EST) – A new clinical trial suggests that pairing bispecific antibodies and antibody-drug conjugates with CAR T-cell therapy may sharply boost one-year progression-free survival for people with aggressive lymphoma.
In just a few years, treatment options for aggressive lymphoma have rapidly advanced. However, many patients show a consistent pattern: powerful new therapies act quickly but often fail to keep the lymphoma at bay permanently, says Jay Spiegel, M.D., a transplant and cellular therapy physician at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine.
Spiegel ...
‘Ready-made’ T-cell gene therapy tackles ‘incurable’ T-cell leukemia
2025-12-08
A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) and Great Ormond Street Hospital (GOSH), has shown promising results in helping children and adults fight a rare and aggressive form of blood cancer called T-cell acute lymphoblastic leukaemia (T-ALL).
The world-first gene therapy (BE-CAR7) uses base-edited immune cells to treat previously untreatable T-cell leukaemia and help patients achieve remission, offering new hope for families facing this aggressive cancer. Base-editing is an advanced version of CRISPR technology, that can precisely change single ...
How brain activity changes throughout the day
2025-12-08
An international team led by the University of Michigan has introduced new methods that reveal which regions of the brain were active throughout the day with single-cell resolution.
Using mouse models, the researchers developed an experimental protocol and a computational analysis to follow which neurons and networks within the brain were active at different times. Published in the journal PLOS Biology, the study provides new insights into brain signaling during sleep and wakefulness, which hints at the bigger questions and goals that motivated the work.
"We undertook this difficult study to understand fatigue," ...
Australian scientists reveal new genetic risk for severe macular degeneration
2025-12-08
Australian researchers have for the first time pinpointed specific genetic changes that increase the risk of severe, sight-threatening forms of age-related macular degeneration (AMD).
A new study, published today in Nature Communications, reveals the specific genetic factors linked to the presence of reticular pseudodrusen - deposits which drive vision loss and are found on the retina of up to 60 per cent of people with advanced AMD.
The research, led by the Centre for Eye Research Australia, WEHI and the University of Melbourne, offers a promising new target for treatments aimed at the most severe ...
GLP-1 receptor agonists likely have little or no effect on obesity-related cancer risk
2025-12-08
Embargoed for release until 5:00 p.m. ET on Monday 8 December 2025
Follow @Annalsofim on X, Facebook, Instagram, Bluesky, and Linkedin
Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their own behalf, but also on behalf of the organization ...
LAST 30 PRESS RELEASES:
Report on academic exchange (colloquium) with Mapua University
Sport in middle childhood can breed respect for authority in adolescence
From novel therapies to first-in-human trials, City of Hope advances blood cancer care at the American Society of Hematology (ASH) annual conference
Research aims to strengthen the security of in-person voting machines
New study exposes hidden Alzheimer’s 'hot spots' in rural Maryland and what they reveal about America’s growing healthcare divide
ASH 2025: Study connects Agent Orange exposure to earlier and more severe cases of myelodysplastic syndrome
ASH 2025: New data highlights promise of pivekimab sunirine in two aggressive blood cancers
IADR elects George Belibasakis as vice-president
Expanding the search for quantum-ready 2D materials
White paper on leadership opportunities for AI to increase employee value released by University of Phoenix College of Doctoral Studies
ASH 2025: New combination approach aims to make CAR T more durable in lymphoma
‘Ready-made’ T-cell gene therapy tackles ‘incurable’ T-cell leukemia
How brain activity changes throughout the day
Australian scientists reveal new genetic risk for severe macular degeneration
GLP-1 receptor agonists likely have little or no effect on obesity-related cancer risk
Precision immunotherapy to improve sepsis outcomes
Insilico Medicine unveils winter edition of Pharma.AI, accelerating the path to pharmaceutical superintelligence
Study finds most people trust doctors more than AI but see its potential for cancer diagnosis
School reopening during COVID-19 pandemic associated with improvement in children’s mental health
Research alert: Old molecules show promise for fighting resistant strains of COVID-19 virus
Journal of Nuclear Medicine Technology supplement highlights advances in theranostics and opportunities for growth
New paper rocks earthquake science with a clever computational trick
ASH 2025: Milder chemo works for rare, aggressive lymphoma
Olfaction written in bones: New insights into the evolution of the sense of smell in mammals
Engineering simulations rewrite the timeline of the evolution of hearing in mammals
New research links health impacts related to 'forever chemicals' to billions in economic losses
Unified EEG imaging improves mapping for epilepsy surgery
$80 million in donations propels UCI MIND toward world-class center focused on dementia
Illinois research uncovers harvest and nutrient strategies to boost bioenergy profits
How did Bronze Age plague spread? A sheep might solve the mystery
[Press-News.org] New study exposes hidden Alzheimer’s 'hot spots' in rural Maryland and what they reveal about America’s growing healthcare divideNew research shows that where a person lives can determine whether they receive timely diagnosis and care or whether they fall through the cracks